MedTrace Logo

Tissue-Specific Metabolic Reprogramming in Diabetic Complications

NCT01823406 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2018-06-28

No results posted yet for this study

Summary

We will perform blood sugar studies to assess changes in metabolic (biochemical processes that occur within us) profiles associated with high blood sugar and diabetes.

Conditions

  • Type 1 Diabetes Mellitus

Interventions

PROCEDURE

Euglycemic clamp (normal blood sugar clamp) for 4 hours

PROCEDURE

hyperglycemic clamp (elevated blood sugar to 300) for 4 hours

Sponsors & Collaborators

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    collaborator NIH

  • University of Michigan

    lead OTHER

Principal Investigators

  • Rodica Pop-Busui, MD,PhD. · University of Michigan

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2017-08-31
Completion
2017-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01823406 on ClinicalTrials.gov